LA

Labiana Health SAMAD Labiana Stock Report

Last reporting period 30 Jun, 2023

Updated 21 Oct, 2024

Last price

Market cap $B

0.038

Micro

Exchange

XMAD - Bolsa de Madrid

LAB.MC Stock Analysis

LA

Uncovered

Labiana Health SA is uncovered by Eyestock quantitative analysis.

Market cap $B

0.038

Dividend yield

Shares outstanding

6.188 B

Labiana Health SA manufactures sterile and lyophilized dosage forms. The company is headquartered in Pozuelo De Alarcon, Madrid and currently employs 477 full-time employees. The company went IPO on 2022-06-24. The Firm, through its subsidiaries, is engaged in the development, manufacturing and marketing of animal and human medicines. The Company’s main activities are: Drug research and development (R&D), which includes galenic and analytical development; Drug manufacturing, which focuses on formulation development, formulation optimization, bacterial vaccine manufacturing, among others; Regulatory services, which carries out registration procedures for pharmaceutical products in world markets. The Company, through its subsidiaries, is present in Ecuador, Mexico, Serbia and Turkey.

View Section: Eyestock Rating